Cargando…
L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
NG-nitro-L-arginine methyl ester (L-NAME) has been used extensively as a paradigmatic inhibitor of NO synthase and has been shown to cause antinociception in several experimental models. We describe here how L-NAME produced a dose-dependent antinociceptive effect when injected intraperitoneally in t...
Autores principales: | Duarte, I D, Ferreira, S H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781740/ https://www.ncbi.nlm.nih.gov/pubmed/10877451 |
Ejemplares similares
-
L-arginine-NO-cGMP signalling pathway in pancreatitis
por: Buchwalow, Igor, et al.
Publicado: (2013) -
Role of L-arginine/NO/cGMP/K(ATP) channel signaling pathway in the central and peripheral antinociceptive effect of thymoquinone in rats
por: Parvardeh, Siavash, et al.
Publicado: (2018) -
Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
por: Tang, Haiyang, et al.
Publicado: (2017) -
The Involvement of l-Arginine-Nitric Oxide-cGMP-ATP-Sensitive K(+) Channel Pathway in Antinociception of BBHC, a Novel Diarylpentanoid Analogue, in Mice Model
por: Ong, Hui Ming, et al.
Publicado: (2021) -
Participation of the NO/cGMP/K(+)ATP pathway in the antinociception induced by Walker tumor bearing in rats
por: Barbosa, A.L.R., et al.
Publicado: (2012)